Comprehensive Analysis of Milk-Derived Extracellular Vesicle Uptake in Intestinal Stem Cell Organoid Models

Study Background and Research Question

Extracellular vesicles (EVs) are nano-sized, membrane-bound structures playing a pivotal role in cellular communication by transferring bioactive molecules such as proteins, nucleic acids, and metabolites. Among these, milk-derived extracellular vesicles (MEVs) have gained increasing attention due to their robust gastrointestinal stability, ease of isolation, and promising potential for therapeutic and drug delivery applications. While previous studies have characterized the beneficial effects of MEVs on intestinal cell lines—such as enhanced proliferative capacity and barrier function—their physiological actions on more representative, stem cell–based intestinal models remained largely unexplored. The reference study sought to address this knowledge gap by establishing porcine intestinal stem cell (ISC)-based organoid models and systematically investigating the mechanisms and functional impact of MEV uptake in these systems (reference study).

Key Innovation from the Reference Study

The primary innovation of this research lies in combining regionally sourced porcine ISC-derived organoid models with carefully isolated MEVs to examine the physiological relevance of MEV uptake and function. Unlike previous studies using immortalized cell lines, this approach leverages organoid monolayers and polarity-defined structures (apical-out and basal-out organoids) to more accurately recapitulate the cellular complexity and architecture of the native intestinal epithelium. Such models enable more precise dissection of region- and polarity-specific uptake mechanisms for MEVs and their subsequent influence on ISC stemness and differentiation programs.

Methods and Experimental Design Insights

The study commenced with the isolation of MEVs from pooled porcine milk using differential ultracentrifugation, ensuring high yield and purity. Three healthy Large White pigs provided mature milk at two weeks postpartum, which was processed within 24 hours to minimize degradation. For the recipient models, ISCs were harvested from the duodenum, jejunum, ileum, and colon of suckling piglets. These cells were then cultured to generate three distinct organoid formats: basal-out organoids (with basolateral surfaces exposed), organoid monolayers (flattened cultures facilitating access to the apical surface), and apical-out organoids (with apical surfaces externally oriented).

Physiological properties were validated by assessing the composition of intestinal epithelial cell subtypes, epithelial barrier integrity, and fatty acid uptake capability in each model. Uptake of MEVs was tracked using fluorescent labeling and microscopic analysis, allowing direct visualization of vesicle internalization, while gene expression changes related to stemness and differentiation were quantified through transcriptomic techniques. Importantly, the study employed mechanistic inhibitors of endocytosis—such as known dynamin GTPase activity inhibitors—to delineate the cellular uptake pathways of MEVs in the various organoid models (internal article).

Core Findings and Why They Matter

The research demonstrated clear region- and polarity-specific differences in MEV uptake. Both organoid monolayers and apical-out organoids, but not basal-out organoids, efficiently internalized porcine MEVs via the apical surface of intestinal epithelial cells. This polarity dependence mirrors physiological exposure in vivo, where dietary and milk-derived vesicles encounter the intestinal lumen. Moreover, MEV treatment upregulated expression of genes associated with ISC stemness and differentiation, particularly in colon-derived ISC models. Notably, the use of endocytosis inhibitors significantly suppressed MEV internalization, confirming that active, dynamin-mediated endocytic pathways are required for vesicle uptake. These results advance mechanistic understanding of how dietary EVs modulate intestinal cellular behavior, with implications for both basic physiology and the development of MEV-based therapeutic strategies (reference study).

Comparison with Existing Internal Articles

This work builds on and extends prior research on MEV uptake and function in organoid models. For example, the internal article "Milk-Derived Extracellular Vesicle Uptake in ISC Organoid Models" provides a rigorous exploration of region-specific internalization and gene expression changes in the gut epithelium, similarly highlighting the significance of using physiologically relevant ISC-based platforms. Another related piece, "Region-Specific Uptake of Milk EVs in Intestinal Stem Cell Organoids", underscores the value of polarity-controlled organoid systems for dissecting membrane trafficking and endocytosis research. The present study’s direct comparison of different organoid orientations and its use of endocytosis inhibitors, such as dynamin GTPase activity blockers, represents a methodological advance that enables more granular mechanistic insight into MEV uptake. These findings are highly relevant for researchers seeking to model and manipulate membrane remodeling processes in vitro.

Limitations and Transferability

Despite the methodological rigor, several limitations must be acknowledged. First, the models were derived from porcine tissue, which, while physiologically similar to the human intestine, may not fully recapitulate species-specific responses. Second, the in vitro organoid systems, though more representative than cell lines, cannot entirely mimic the complexity of the in vivo gut environment, including immune and microbial components. Third, the study focused on acute MEV exposure and did not address potential long-term or systemic effects. Finally, while the mechanistic experiments employed established endocytosis inhibitors, the specificity and off-target effects of these compounds can vary, necessitating confirmation using genetic approaches or complementary inhibitors. Nonetheless, the approaches and insights presented are readily transferable to other systems investigating dietary EVs, membrane trafficking, and cellular uptake mechanisms.

Protocol Parameters

• Milk collection and MEV isolation: Collect mature milk from healthy donors at 10–14 days postpartum; pool and process within 24 hours at 4°C. Isolate MEVs by differential ultracentrifugation to maximize yield and purity.
• ISC-derived organoid establishment: Isolate crypts from duodenum, jejunum, ileum, or colon; embed in Matrigel and culture with growth factor-enriched media for 7–10 days to form basal-out or apical-out organoids, or dissociate and plate for monolayer formation.
• MEV labeling and uptake assay: Fluorescently label MEVs and incubate with organoids or monolayers for defined periods (e.g., 1–24 hours); visualize internalization using confocal microscopy.
• Use of endocytosis inhibitors: Include dynamin GTPase activity inhibitors (e.g., N,N,N-trimethyltetradecan-1-aminium bromide) during MEV exposure to test for pathway dependence; optimize concentration and incubation based on inhibitor and organoid sensitivity.
• Gene expression analysis: Extract RNA post-treatment and assess ISC stemness/differentiation markers via RT-qPCR or transcriptomic profiling.

Research Support Resources

Researchers aiming to dissect membrane trafficking and endocytosis in stem cell–based organoid systems can leverage potent cellular uptake mechanism inhibitors to probe vesicle internalization pathways. For practical workflows, MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide, SKU B7620) is a well-characterized inhibitor of dynamin GTPase activity, widely used in membrane remodeling studies and endocytosis research compound applications. According to the product information, it is suitable for research use in organoid and stem cell models requiring precise control of vesicle scission and uptake. For guidance on protocol optimization, see recent workflow articles such as MitMAB: Precision Control in Endocytosis and Organoid Models. Please note that MitMAB is intended for research applications only and not for diagnostic or therapeutic use.